Sepsis and survival in heart patients
Part of Infections clinical trials.
This study looks at how sepsis and other infections affect survival in hospitalized heart patients. It is designed for people who are being treated for a heart condition and either have no infection or have a specific type of infection or heart inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are a cardiology patient without an infection, or you have been diagnosed with sepsis, a hospital-acquired infection, myocarditis, endocarditis, or pericarditis.
- You do not have a serious chronic condition like an autoimmune disease or kidney/liver failure.
- You are not taking steroids or other immune-suppressing medications.
- You do not have cancer or a disease that weakens the immune system (like HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how checking heart function with an ultrasound during early sepsis treatment can help guide fluid and medication decisions. It may lead to better recovery by tailoring treatment to each patient's heart.
This study looks at how well the heart and blood vessels work together in people with sepsis or septic shock. It may help doctors understand heart function better during serious infections, which could lead to improved care.
This study looks at how the heart and blood vessels respond during a severe infection called sepsis. It may help doctors understand and treat this condition better.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how a measurement from a bedside heart ultrasound changes while treating people with sepsis or septic shock. It may help doctors understand how to monitor response to treatment using a quick ultrasound test.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.